Skip to main content
Clinical Trials/NCT06134076
NCT06134076Not yet recruitingNot Applicable

Impact of Fermented Pulses on Inflammation and the Gut Microbiota

Penn State University0 sites30 target enrollmentStarted: September 1, 2027Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
30
Primary Endpoint
Change in inflammation levels from baseline and between interventions

Study Overview

Brief Summary

The goal of this clinical trial is to learn about the effects of consuming fermented pulses (certain types of legumes like chickpeas or lentils) in healthy people. The main questions it aims to answer are:

  1. How does consuming the fermented foods impact the gut microbiome?
  2. Does this interaction between the fermented foods and the gut microbiome affect inflammation?

Participants will be asked to consume two sets of prepared meals, one containing unfermented pulses, the other containing fermented pulses.

Researchers will compare the gut microbiome and inflammation between these two diets.

Detailed Description

The rationale for the research is that fermentation of pulses can reduce the concentration of compounds that suppress butyrate producing bacteria and butyrate production. This will in turn boost butyrate production during consumption of these fermented pulses relative to that in unfermented pulses. This in turn will lead to lower inflammation in people consuming fermented pulses. To best study this question the investigators will utilize a cross-over design trial where participants will consume daily meals containing either fermented or unfermented pulses (chickpeas), followed by a washout period and then a period of consuming the other type of pulse. The investigators hypothesize that those consuming the fermented pulses will experience a significant decrease in inflammatory markers driven by increased butyrate production by gut bacteria.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Double (Participant, Outcomes Assessor)

Masking Description

Subjects will receive both interventions labeled only as 1 or 2. The study team assessing inflammation and microbiome will not know the identity of intervention 1 or 2. The preparer of the meals will also conduct dietary recall interviews with subjects and will know the identities of the interventions.

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy adults

Exclusion Criteria

  • Taken antibiotics within the past month
  • Taking any medication for the management of diabetes or obesity
  • Are pregnant
  • BMI > 24.9
  • Allergies to pulses or any other meal components

Arms & Interventions

Unfermented Chickpea

Experimental

Intervention: Unfermented chickpea (Other)

Fermented Chickpea

Experimental

Intervention: Fermented chickpea (Other)

Outcomes

Primary Outcomes

Change in inflammation levels from baseline and between interventions

Time Frame: At 2 weeks (baseline), 4 weeks (after first intervention), 8 weeks (after second intervention)

Measured in blood (IL-1β, IL-6, IL-10, IL-12, IFN-γ, TNF-α) and in feces (NGAL, calprotectin)

Secondary Outcomes

  • Change in gut microbiome composition from baseline and between interventions(At 2 weeks (baseline), 4 weeks (after first intervention), 8 weeks (after second intervention))
  • Change in fecal short chain fatty acids from baseline and between interventions(At 2 weeks (baseline), 4 weeks (after first intervention), 8 weeks (after second intervention))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Darrell W. Cockburn, Ph.D.

Assistant Professor

Penn State University

Similar Trials

Comparing Effects of Fermented and... | Clinical Trial